Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News release!

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Feb 23, 2021 11:55am

168 Views

Post# 32637147

RE:News release!

I'd settle for any positive PR at this point.

But if you are asking...How about a frank assessment of the phase 2 trial, the expected path and timeframe going forward and how the company is going to monetize the treatment. I care less from a scientific perspective and more from a business viewpoint in as my underlying assumption is the treatment works.

In other words what's the plan?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale